Back
Ironwood Pharmaceuticals 10K Form
Sell
39
IRWD
Ironwood Pharmaceuticals
Last Price:
8.11
Seasonality Move:
1.24%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-09 | 10Q | IRWD/Ironwood Pharmaceuticals Quarterly |
| 2023-08-09 | 10Q | IRWD/Ironwood Pharmaceuticals Quarterly |
| 2023-05-04 | 10Q | IRWD/Ironwood Pharmaceuticals Quarterly |
| 2022-11-03 | 10Q | IRWD/Ironwood Pharmaceuticals Quarterly |
| 2022-08-04 | 10Q | IRWD/Ironwood Pharmaceuticals Quarterly |
| 2022-05-05 | 10Q | IRWD/Ironwood Pharmaceuticals Quarterly |
Receive IRWD News And Ratings
See the #1 stock for the next 7 days that we like better than IRWD
IRWD Financial Statistics
Sales & Book Value
| Annual Sales: | $442.74M |
|---|---|
| Cash Flow: | $35.62M |
| Price / Cash Flow: | 7.77 |
| Annual Sales: | $-2.21 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -6.51000 |
|---|---|
| Net Income (TTM): | $-1B |
| Gross Margin: | $410.6M |
| Return on Equity: | -1471.81% |
| Return on Assets: | -130.02% |
Ironwood Pharmaceuticals Earnings Forecast
Key Ironwood Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 16 years for IRWD is 100.00%.
- The Selling, General & Administrative Expenses for IRWD have been equal to 35.76% of Gross Profit Margin.
- The Research & Development expenses have been 26.22% of Revenue.
- The Interest Expense is -2.16% of Operating Income.
- The Net Earning history of IRWD is -226.37% of Total Revenues.
- Per Share Earnings over the last 17 years have been positive in 7 years.
Ironwood Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | IRWD |
| CUSIP: | 46333X |
| Website: | ironwoodpharma.com |
Debt
| Debt-to-Equity Ratio: | -2.02 |
|---|---|
| Current Ratio: | 0.84 |
| Quick Ratio: | 0.8 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 10.07 |
IRWD Technical Analysis vs Fundamental Analysis
Sell
39
Ironwood Pharmaceuticals (IRWD)
is a Sell
Is Ironwood Pharmaceuticals a Buy or a Sell?
-
Ironwood Pharmaceuticals stock is rated a Sell
The current Ironwood Pharmaceuticals [IRWD] share price is $8.31. The Score for IRWD is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.